Showing results (1321-1330 of 1,423) with videos related to

Sort By:
Pageof 143
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group StudyRoisin M Connolly, Eric Laille, Ulka Vaishampayan, et al.
Neurology|July 15, 2011
Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophyD M Escolar, L P Hache, P R Clemens, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2021
Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844)Evanthia T Roussos Torres, Christine Rafie, Chenguang Wang, et al.
Muscle & Nerve|February 2, 2019
Twice-weekly glucocorticosteroids in infants and young boys with Duchenne muscular dystrophyAnne M Connolly, Craig M Zaidman, Paul T Golumbek, et al.
Medicine|July 3, 2019
Long-term treatment with eteplirsen in nonambulatory patients with Duchenne muscular dystrophyLindsay N Alfano, Jay S Charleston, Anne M Connolly, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 16, 2015
Evidence- and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis - International League of Dermatological Societies in cooperation with the European Dermatology Forum - Short versionR N Werner, E Stockfleth, S M Connolly, et al.
The New England Journal of Medicine|November 2, 2017
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular AtrophyRichard S Finkel, Eugenio Mercuri, Basil T Darras, et al.
Neurology|March 10, 2012
Pentoxifylline as a rescue treatment for DMD: a randomized double-blind clinical trialD M Escolar, A Zimmerman, T Bertorini, et al.
Neurology|March 16, 2018
A multinational study on motor function in early-onset FSHDJean K Mah, Jia Feng, Marni B Jacobs, et al.
JCO Precision Oncology|July 14, 2018
Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor BoardW Brian Dalton, Patrick M Forde, Hyunseok Kang, et al.
Pageof 143